TET2 and myeloid neoplasm: The effect of Epag on TET2 mutant myeloid neoplasm patient-derived mononuclear cells was tested in 9 patients (5 with biallelic and 4 with monoallelic inactivation of TET2) using colony-forming assays in the presence or absence of Epag (Figure 5C, Supplemental Figure 6, and Supplemental Table 1).